M1336 – Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks

Long description

Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks

Short description

Pts eval ini xm 2 wks

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2024

Last change

January 1, 2024 – No change

Nearby M codes

• M1328 – Patients with a diagnosis of acute vitreous hemorrhage
• M1329 – Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter
• M1330 – Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
• M1331 – Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam
• M1332 – Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks
• M1333 – Acute vitreous hemorrhage
• M1334 – Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter
• M1335 – Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
• M1337 – Acute pvd
• M1338 – Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period
• M1339 – Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period
• M1340 – Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period
• M1341 – Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period
• M1342 – Patients who died during the performance period
• M1343 – Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responses
• M1344 – Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam score